Wikidata

(Q61966958)

English

Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older

clinical trial

In more languages

Statements

title
(PRO#11307) Phase III Randomized Study of Autologous Stem Cell Transplantation With High-dose Melphalan Versus High-dose Melphalan and Bortezomib in Patients With Multiple Myeloma 65 Year or Older (English)
0 references
start time
24 June 2010
0 references
end time
March 2020
0 references
number of participants
208
0 references
research intervention
bortezomib
0 references
melphalan
0 references
minimum age
60 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61966958&oldid=2148534445"